# OmniSeq

> Genomic and immune profiling diagnostics for solid tumors; Roswell Park spinout acquired by Labcorp.

## Why it is interesting

Buffalo precision-oncology lab spun from Roswell Park in 2015 and acquired by Labcorp in July 2021 — a rare Upstate molecular diagnostics exit into a national lab platform.

## Profile

- **Stage:** acquired
- **Status:** acquired
- **Industries:** biotech-life-sciences, healthtech
- **Coverage:** full
- **Last updated:** 2026-07-26

## Key facts

- Founded 2015 — Roswell Park Center of Personalized Medicine commercial spinout, Buffalo, NY
- CAP-accredited, CLIA-licensed molecular diagnostic lab for solid tumor genomic/immune profiling
- Jun 2021: Labcorp and OmniSeq launched OmniSeq INSIGHT NGS platform (pre-close partnership product)
- Acquired by Labcorp (Jul 29, 2021) — oncology portfolio expansion
- Standalone website retired; coverage is historical exit profile

## Related articles

- https://venturecapitaltracker.com/buffalo-startups-and-vc-firms-2026

---
Source: https://venturecapitaltracker.com/startup/omniseq